-+ 0.00%
-+ 0.00%
-+ 0.00%

Aardvark Therapeutics Q1 EPS $(0.71) Down From $(0.55) YoY

Benzinga·05/14/2025 20:42:03
Listen to the news
Aardvark Therapeutics (NASDAQ:AARD) reported quarterly losses of $(0.71) per share. This is a 29.09 percent decrease over losses of $(0.55) per share from the same period last year.